Name: Iron Supplementation: Repletion, Overload, and the Test-First Rule
Creator: Realised
Published: 2026-06-01

Summary

Iron is a genuinely effective, Tier-1 treatment for measured deficiency, especially in menstruating women and pregnancy, but it is a test-first drug, not a wellness top-up: the body has no route to excrete excess, so supplementing without a confirmed need risks overload, the "take iron for energy" pitch fails without a low ferritin behind it, and the premium "gentle chelated" forms buy modest tolerability, not the big absorption win the label implies.

Why Strong

Tier 1 because: efficacy for measured deficiency/IDA rests on decades of RCT and clinical consensus (WHO, NIH ODS, ASH); the alternate-day/hepcidin finding is a direct human absorption trial (Stoffel 2017, Lancet Haematology); the elemental fractions are fixed chemistry; and the overload thresholds and child-poisoning hazard are established clinical and patient-safety facts.

NOT Tier 0.5 because the entry involves genuine practical judgement (who to test, which form, what schedule) and a real two-sided commercial/contrarian controversy, not a single undisputed axiom.
NOT Tier 2 because the core claims are replicated trials plus consensus, not a few suggestive studies; only the bisglycinate-vs-sulfate comparison sits at Tier 2, and the entry treats it as such.

Practical takeaway

The one rule: test ferritin first; supplement only on a measured deficiency; then take the cheapest tolerated salt as a single morning dose, alternate-day where you can.
• Test before you treat. Get ferritin (and ideally TSAT). Supplement only if it confirms deficiency. If you're tired but ferritin is normal, iron is not your answer, look elsewhere (see fatigue_cross_pillar_diagnostic, and consider B12, see b12_and_b_complex_supplementation).
• Form: ferrous sulfate (~20% elemental) or fumarate (~33%) first-line, both cheap. Reach for bisglycinate only if sulfate/fumarate genuinely upsets your gut, it has a modest tolerability edge at 3–5× the cost, not a real absorption advantage.
• Dose: typical repletion is 60–120 mg elemental/day; WHO pregnancy guidance is 30–60 mg elemental/day. Read the elemental figure on the supplement-facts panel, not the salt weight on the front.
• Timing/schedule: single morning dose, alternate-day where tolerated, for higher fractional absorption and fewer GI effects. Empty stomach plus vitamin C improves absorption of the salts; taking it with food reduces absorption but eases nausea, a reasonable trade if side effects are the barrier.
• Who genuinely benefits: menstruating women (especially heavy bleeding), pregnancy, and anyone with lab-confirmed iron deficiency or IDA.
• Who should NOT supplement: anyone without measured deficiency; men and post-menopausal women (who rarely need it); and anyone with iron overload or hereditary haemochromatosis (TSAT >45%, or ferritin >200 F / >300 M), who should avoid iron and be managed by phlebotomy.
• Recheck. Iron is not a forever supplement. Re-test ferritin during repletion and stop when replete; don't run it open-endedly without monitoring (the overload case reports are exactly this failure).

Evidence detail

Why This Entry Exists

"Tired? You might be low on iron" is one of the most profitable lines in the supplement aisle, and it is wrong often enough to be dangerous. Iron is unusual among the things people buy off a shelf: it is a near-perfect remedy for a specific, measurable problem and a meaningfully harmful thing to take when you don't have that problem. The body actively absorbs iron but has no regulated way to get rid of it, so an unneeded daily dose doesn't just waste money, it slowly loads tissue that has nowhere to put it.

This entry is the home of record for the two questions a user actually has when they reach for iron: do I need it, and if so, what and how do I take it. The answers run against the marketing in both directions. The first answer is "test ferritin first, supplement only on a measured deficiency." The second is "cheap ferrous sulfate or fumarate, a single morning dose, alternate-day where tolerated, and read the elemental figure not the salt weight."

What bad advice this protects against, in both directions:
• "Take iron for energy/tiredness" (the supplement-seller pitch) → fatigue without a measured low ferritin is usually not iron, and supplementing blind risks overload in someone who was never deficient.
• "Iron is a pro-oxidant, avoid it" (the contrarian wellness overcorrection) → this leaves genuinely deficient menstruating and pregnant people undertreated for a condition with a clean, effective fix.
• Paying up for "gentle chelated bisglycinate" → the real-world edge over ferrous sulfate is tolerability, not a large absorption gain; cheap salts remain first-line.
• Reading salt weight as iron → "325 mg ferrous sulfate" is only ~65 mg of elemental iron; confusing the two massively overstates the dose delivered.

It does not own the full deficiency-screening workup (that is micronutrient_deficiency_screening) or the general label-reading principle (that is supplement_form_elemental_dose_and_bioavailability). It owns the iron-specific decision: when to supplement, what form, what dose, what schedule, and the overload and child-poisoning hazards that make iron different from every other mineral on the shelf.

Evidence

1. Iron corrects deficiency and iron-deficiency anaemia effectively (Tier 1). This is settled across decades of RCT and clinical evidence consolidated by the WHO, the NIH Office of Dietary Supplements, and the American Society of Hematology. For lab-confirmed iron deficiency and iron-deficiency anaemia (IDA), oral iron restores ferritin, haemoglobin, and the symptoms that genuinely track deficiency. The efficacy is not in question; the targeting is the whole game.

2. The genuine-need populations are well-defined (Tier 1). Menstruating women, especially with heavy menstrual bleeding, lose iron monthly and are the largest deficient group. Pregnancy roughly doubles iron requirements; WHO recommends 30–60 mg elemental iron daily antenatally (or 120 mg weekly intermittent dosing where population anaemia prevalence is below ~20%). Outside these groups, lab-confirmed deficiency is the only trigger: men and post-menopausal women rarely need iron, because without monthly losses they retain it.

3. Alternate-day, single-morning dosing beats daily and divided dosing for absorption (Tier 1). Stoffel et al. (2017, Lancet Haematology), in iron-depleted women dosed with 60 mg elemental iron, found alternate-day single doses gave higher fractional absorption (~21.8%) than consecutive-day dosing (~16.3%), and that twice-daily split dosing actively raised hepcidin and lowered absorption. The counterintuitive result: spacing doses out absorbs more iron per milligram, with fewer GI side effects, than cramming more in more often.

4. Elemental-vs-salt weight is real and label-relevant (Tier 1, deterministic chemistry). Per NIH ODS, the elemental fraction of the common salts is fixed by molar mass: ferrous fumarate ~33%, ferrous sulfate ~20%, ferrous gluconate ~12%. So a "325 mg ferrous sulfate" tablet delivers only ~65 mg elemental iron, and a "325 mg ferrous gluconate" tablet only ~36 mg. The salt weight on the front of the pack is not the dose that matters.

5. GI side effects are dose-driven (Tier 1). Per NIH ODS, supplemental iron around 45 mg/day and above commonly causes nausea and constipation. This is mechanistically why lower-dose and alternate-day regimens are better tolerated, and why "more, faster, daily, split" makes side effects worse without speeding repletion.

6. The "gentle chelate" superiority claim is overstated (Tier 2 / mixed). Head-to-head trials of ferrous bisglycinate against ferrous sulfate in people with normal stomach acid are mixed-to-comparable on absorption. The real, modest advantage of bisglycinate is tolerability, not a large bioavailability win. Most "bisglycinate is dramatically better absorbed" content traces to supplement-seller sites, not independent absorption studies.

7. Overload is a real, monitorable harm (Tier 1). Because iron has no excretion route, supplementing without need can drive overload. Hereditary haemochromatosis and other overload states are diagnosed at transferrin saturation (TSAT) >45% or ferritin >200 µg/L (women) / >300 µg/L (men) (StatPearls/NIH Bookshelf), and treated by phlebotomy with iron supplements avoided. A published Cureus case report describes an IDA patient continued on iron without monitoring who was later found in frank overload (ferritin 1480 ng/mL, ~100% saturation), the clean illustration of why "set it and forget it" iron is wrong.

Mechanism

Why iron is uniquely unforgiving of over-supplementation. Humans regulate iron almost entirely at absorption, not excretion. There is no physiological pathway to dump a surplus, so once iron is in, it stays, accumulating in liver, heart, and endocrine tissue. Every other mineral on the shelf has some excretory release valve; iron does not. This single fact is why "just in case" iron is a categorically worse idea than "just in case" magnesium or zinc.

Why alternate-day dosing absorbs more (hepcidin). A single iron dose transiently raises hepcidin, the hormone that shuts down further gut iron uptake, and that suppression lasts roughly 24–48 hours. So a second dose taken the same day, or a dose taken every day, partly lands during a hepcidin-blunted window and absorbs poorly. Spacing doses to alternate days lets hepcidin fall back to baseline between doses, so each dose absorbs a higher fraction. This is the mechanism behind the Stoffel finding, and it overturns the intuitive "take more to get more."

Why fatigue is a bad reason to supplement blind. Fatigue is multi-causal: sleep debt, under-recovery, low mood, thyroid, B12, and many other inputs all present as tiredness. Iron only relieves fatigue that is caused by iron deficiency. Without a measured low ferritin, supplementing treats a guess, and the body's no-excretion rule means a wrong guess accumulates rather than washes out.

Why salt weight misleads. A ferrous salt is iron bound to a carrier (sulfate, fumarate, gluconate). The label usually lists the whole salt's weight; the iron is a fixed fraction of that molecular weight. So the same "325 mg" front number delivers 65 mg of iron as sulfate but only 36 mg as gluconate. (This is the iron instance of the general principle in supplement_form_elemental_dose_and_bioavailability.)

Risks And Contraindications

• STORAGE / CHILD SAFETY (the most important line in this entry). Keep iron locked away from children. As little as ~600 mg elemental iron, roughly 10 ferrous sulfate tablets, can kill a small child. Iron was the leading cause of poisoning death in children under 6 in the US (1983–1990); deaths fell substantially after packaging and labelling reform, which is precisely why the hazard is easy to forget now. Treat iron like a medicine, not a vitamin.
• Overload has no off-switch. With no excretion route, unneeded iron accumulates. Don't supplement without a measured deficiency, and don't continue indefinitely without rechecking ferritin/TSAT.
• Haemochromatosis / iron overload is a hard contraindication. TSAT >45% or ferritin >200 µg/L (F) / >300 µg/L (M) warrants avoiding iron and a clinical workup; treatment is phlebotomy, not supplements.
• GI side effects (nausea, constipation, dark stools) are common at ~45 mg/day and above. The fix is lower dose, alternate-day, or with food, or switching to bisglycinate, not abandoning treatment if you're genuinely deficient.
• Interactions/absorption: calcium, tea/coffee (tannins), and antacids/PPIs blunt iron absorption; vitamin C aids it. Iron also reduces absorption of certain antibiotics and thyroid medication, separate doses by a few hours.
• Not a fatigue cure. Supplementing iron for tiredness without measured deficiency is the central misuse this entry exists to prevent: it doesn't treat the actual cause and it loads iron you can't shed.

Controversy

Nature: commercial and contrarian, with overstatement at both poles.

Position A — "Iron is for energy; if you're tired, top up." The supplement-marketing take.
• Best evidence: in genuinely deficient people (common in menstruating women), correcting low iron really does resolve fatigue, so the pitch isn't fabricated, it's overgeneralised.
• Where it's wrong: most fatigue is not iron deficiency, and the body cannot excrete a surplus. "Top up for energy" without a measured low ferritin is how you load iron into someone who never needed it. Test first.

Position B — "Iron is a pro-oxidant; avoid supplementing it." The contrarian wellness take.
• Best evidence: free iron does catalyse oxidative reactions, and unneeded supplementation is genuinely harmful, so as a caution against blind use it has a real point.
• Where it's wrong: it overcorrects into telling deficient people, often pregnant or heavily menstruating women, to avoid a safe, effective, sometimes essential treatment. Deficiency has its own real harms; the answer is targeting, not blanket avoidance.

The funding/bias dimension: sellers profit from blanket "iron for energy/fatigue" messaging and from upselling premium "gentle/chelated" bisglycinate at 3–5× the price of ferrous sulfate, where the honest advantage is modest tolerability rather than a large absorption gain. The contrarian pole, by contrast, sells a clean "avoid it" story that earns clicks but undertreats real deficiency. The low-conflict, non-commercial sources (NIH ODS, WHO, ASH, and the hematology RCT literature) converge in the middle.

Realised Position: Iron is a test-first drug. Measure ferritin (and TSAT) before supplementing; treat only confirmed deficiency. Use the cheapest tolerated salt (ferrous sulfate or fumarate), a single morning dose, alternate-day where tolerated, reading the elemental figure. Reserve bisglycinate for GI intolerance. Never supplement without measured need, never run it unmonitored, and store it like a poison around children, because for a small child it is one.

Cross-Pillar Connections

• Diet (supplement_form_elemental_dose_and_bioavailability): the parent label-literacy principle, iron is its sharpest worked example (salt weight vs elemental, and the "read the elemental line" rule).
• Diet / Cross-pillar (micronutrient_deficiency_screening): owns the whether and how to test workup; this entry defers to it for the screening and dosing-to-ferritin logic and supplies the iron-specific treatment detail.
• Cross-pillar (fatigue_cross_pillar_diagnostic): the destination for "I'm tired" when ferritin is normal, iron is only one branch of a multi-cause diagnostic, and this entry hands off the non-iron causes there.
• Diet (b12_and_b_complex_supplementation): the other classic "tired and possibly deficient" nutrient, frequently the right answer when iron is not.
• Diet (zinc_supplementation_and_copper_balance): a sibling mineral entry on the same theme, supplementing one mineral blind can unbalance others; minerals compete for absorption.

What would change our mind

Falsifiability: explicit upgrade/downgrade criteria from source

• We'd elevate "gentle chelate" forms if independent, adequately-powered head-to-head RCTs showed bisglycinate producing meaningfully greater repletion (ferritin/haemoglobin recovery) than ferrous sulfate at matched elemental doses, rather than just better tolerability.
• We'd revise the alternate-day guidance if larger trials on hard clinical endpoints (time-to-repletion, IDA resolution) showed daily dosing matched or beat alternate-day in practice, not just on single-dose fractional-absorption metrics.
• We'd soften the test-first rule only if a population were identified in whom empiric iron is net-beneficial without measurement, which, given the no-excretion physiology and the overload case literature, is a high bar.
• What would NOT move us: the elemental-vs-salt arithmetic (deterministic chemistry), the no-excretion physiology, the child-poisoning hazard, or the haemochromatosis thresholds, these are settled.

Industry bias note

Structural incentives the evidence base may reflect

This is a topic where the supplement industry profits chiefly from blanket use and premium forms, which is exactly why the independent/consensus sources are the anchor.
• The "iron for energy" end: undifferentiated "tired? take iron" messaging sells iron to people who were never deficient, the high-volume, low-targeting business model. It ignores both the multi-causal nature of fatigue and the no-excretion overload risk.
• The premium-form end: "gentle," "chelated," "bisglycinate" forms command 3–5× ferrous sulfate's price on an absorption story that head-to-head data don't support; the real edge is tolerability.
• The contrarian end: "iron is a pro-oxidant, avoid it" wellness content overcorrects and undertreats genuinely deficient menstruating and pregnant people, a different bias, equally unhelpful to the user.
• The clean signal: NIH ODS, WHO antenatal guidance, ASH, the Stoffel 2017 RCT, and the haemochromatosis/poisoning literature converge on the boring, correct answer, test first, cheapest effective salt, alternate-day single morning dose, treat measured need, which Realised weights over all three commercial/contrarian poles.

Iron Supplementation: Repletion, Overload, and the Test-First Rule